Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study

Kalman JL, Papiol S, Forstner AJ, Heilbronner U, Degenhardt F, Strohmaier J, Adli M, Adorjan K, Akula N, Alda M, Anderson-Schmidt H, Andlauer TF, Anghelescu IG, Ardau R, Arias B, Arolt V, Aubry JM, Backlund L, Bartholdi K, Bauer M, Baune BT, Becker T, Bellivier F, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Brichant-Petitjean C, Budde M, Cervantes P, Chillotti C, Cichon S, Clark SR, Colom F, Comes AL, Cruceanu C, Czerski PM, Dannlowski U, Dayer A, Del Zompo M, DePaulo JR, Dietrich DE, Étain B, Ethofer T, Falkai P, Fallgatter A, Figge C, Flatau L, Folkerts H, Frisen L, Frye MA, Fullerton JM, Gade K, Gard S, Garnham JS, Goes FS, Grigoroiu-Serbanescu M, Gryaznova A, Hake M, Hauser J, Herms S, Hoffmann P, Hou L, Jäger M, Jamain S, Jiménez E, Juckel G, Kahn JP, Kassem L, Kelsoe J, Kittel-Schneider S, Kliwicki S, Klohn-Sagatholislam F, Koller M, König B, Konrad C, Lackner N, Laje G, Landén M, Lang FU, Lavebratt C, Leboyer M, Leckband SG, Maj M, Manchia M, Martinsson L, McCarthy MJ, McElroy SL, McMahon FJ, Mitchell PB, Mitjans M, Mondimore FM, Monteleone P, Nieratschker V, Nievergelt CM, Novák T, Ösby U, Pfennig A, Potash JB, Reich-Erkelenz D, Reif A, Reimer J, Reininghaus E, Reitt M, Ripke S, Rouleau GA, Rybakowski JK, Schalling M, Scherk H, Schmauß M, Schofield PR, Schubert KO, Schulte EC, Schulz S, Senner F, Severino G, Shekhtman T, Shilling PD, Simhandl C, Slaney CM, Spitzer C, Squassina A, Stamm T, Stegmaier S, Stierl S, Stopkova P, Thiel A, Tighe SK, Tortorella A, Turecki G, Vieta E, Veeh J, von Hagen M, Wigand ME, Wiltfang J, Witt S, Wright A, Zandi PP, Zimmermann J, Nöthen M, Rietschel M, Schulze TG (2019)


Publication Type: Journal article

Publication year: 2019

Journal

Book Volume: 21

Pages Range: 68-75

Journal Issue: 1

DOI: 10.1111/bdi.12659

Abstract

Objectives: Bipolar disorder (BD) with early disease onset is associated with an unfavorable clinical outcome and constitutes a clinically and biologically homogenous subgroup within the heterogeneous BD spectrum. Previous studies have found an accumulation of early age at onset (AAO) in BD families and have therefore hypothesized that there is a larger genetic contribution to the early-onset cases than to late onset BD. To investigate the genetic background of this subphenotype, we evaluated whether an increased polygenic burden of BD- and schizophrenia (SCZ)-associated risk variants is associated with an earlier AAO in BD patients. Methods: A total of 1995 BD type 1 patients from the Consortium of Lithium Genetics (ConLiGen), PsyCourse and Bonn-Mannheim samples were genotyped and their BD and SCZ polygenic risk scores (PRSs) were calculated using the summary statistics of the Psychiatric Genomics Consortium as a training data set. AAO was either separated into onset groups of clinical interest (childhood and adolescence [≤18 years] vs adulthood [>18 years]) or considered as a continuous measure. The associations between BD- and SCZ-PRSs and AAO were evaluated with regression models. Results: BD- and SCZ-PRSs were not significantly associated with age at disease onset. Results remained the same when analyses were stratified by site of recruitment. Conclusions: The current study is the largest conducted so far to investigate the association between the cumulative BD and SCZ polygenic risk and AAO in BD patients. The reported negative results suggest that such a polygenic influence, if there is any, is not large, and highlight the importance of conducting further, larger scale studies to obtain more information on the genetic architecture of this clinically relevant phenotype.

Involved external institutions

Charité - Universitätsmedizin Berlin DE Germany (DE) Klinikum der Universität München (LMU Klinikum) DE Germany (DE) National Institute of Mental Health Information Resource Center US United States (USA) (US) Dalhousie University CA Canada (CA) Max-Planck-Institut für Psychiatrie (Deutsche Forschungsanstalt für Psychiatrie) DE Germany (DE) Rheinische Friedrich-Wilhelms-Universität Bonn DE Germany (DE) Ruprecht-Karls-Universität Heidelberg DE Germany (DE) DR. FONTHEIM Mentale Gesundheit / Private Neuropathic Hospital Dr. med. Kurt Fontheim DE Germany (DE) Università degli Studi di Cagliari IT Italy (IT) Universitat de Barcelona (UB) / University of Barcelona ES Spain (ES) Westfälische Wilhelms-Universität (WWU) Münster DE Germany (DE) Geneva University Hospitals / Hôpitaux universitaires de Genève (HUG) CH Switzerland (CH) Karolinska Institute SE Sweden (SE) Universitätsklinikum Carl Gustav Carus Dresden DE Germany (DE) University of Adelaide AU Australia (AU) Universität Ulm DE Germany (DE) Mayo Clinic US United States (USA) (US) Universitätsklinikum Göttingen DE Germany (DE) McGill University Health Centre (MUHC) / Centre universitaire de santé McGill CA Canada (CA) VA San Diego Healthcare System US United States (USA) (US) Università degli studi della Campania Luigi Vanvitelli IT Italy (IT) Lindner Center of HOPE US United States (USA) (US) University of New South Wales (UNSW) AU Australia (AU) Johns Hopkins University (JHU) US United States (USA) (US) Universitätsklinikum Tübingen DE Germany (DE) National Institute of Mental Health (NIMH) / Národní ústav duševního zdraví (NUDZ) CZ Czech Republic (CZ) Neuroscience Research Australia NeuRA AU Australia (AU) Sigmund-Freud-Privatuniversität Wien (SFU) / Sigmund Freud University AT Austria (AT) Asklepios Kliniken DE Germany (DE) Centre Hospitalier Charles Perrens (CHCP) FR France (FR) Agaplesion Diakonieklinikum Rotenburg DE Germany (DE) Poznan University of Medical Sciences / Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu PL Poland (PL) University of Iowa US United States (USA) (US) Università degli Studi di Perugia IT Italy (IT) Douglas Mental Health University Institute CA Canada (CA) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) Klinikum Werra-Meißner / Clinical Center Werra-Meißner DE Germany (DE) Centre hospitalier universitaire Henri-Mondor (CHU Henri-Mondor) FR France (FR) US National Institutes of Health (NIH) US United States (USA) (US) Städtisches Klinikum Lüneburg DE Germany (DE) Klinikum Bremen-Ost DE Germany (DE) Karl-Jaspers-Klinik DE Germany (DE) Université Paris Cité FR France (FR) Medizinische Universität Graz AT Austria (AT) AMEOS Klinikum Hildesheim DE Germany (DE) AMEOS Klinik Osnabrück DE Germany (DE) Bezirkskliniken Schwaben DE Germany (DE) Klinikum Wilhelmshaven gGmbH DE Germany (DE) Ruhr-Universität Bochum (RUB) DE Germany (DE) Université de Lorraine FR France (FR) Stiftung Kreuznacher Diakonie DE Germany (DE) Sahlgrenska University Hospital / Sahlgrenska Universitetssjukhuset SE Sweden (SE)

How to cite

APA:

Kalman, J.L., Papiol, S., Forstner, A.J., Heilbronner, U., Degenhardt, F., Strohmaier, J.,... Schulze, T.G. (2019). Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study. Bipolar Disorders, 21(1), 68-75. https://doi.org/10.1111/bdi.12659

MLA:

Kalman, Janos L., et al. "Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study." Bipolar Disorders 21.1 (2019): 68-75.

BibTeX: Download